Sort
326,823 grants matching “clinical trial”
A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Alzheimer's Disease
$1,543,652Adam Peter Mecca · Yale University · R01 · FY2022 · AG
MEthotrexate Response in Treatment of UC - MERIT-UC
$1,543,652Hans H. Herfarth · Univ Of North Carolina Chapel Hill · U01 · FY2015 · DK
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,543,614Robert A. Gramzinski · Walter Reed Army Institute Of Research · UM1 · FY2018 · AI
Diabetes Research Center
$1,543,570Steven E Kahn · University Of Washington · P30 · FY2013 · DK
Specialized Program of Translational Research In Acute Stroke at the Partners
$1,543,549Karen L. Furie · Massachusetts General Hospital · P50 · FY2009 · NS
Primary Immune Deficiency Treatment Consortium
$1,543,499Morton Cowan · University Of California, San Francisco · U54 · FY2015 · AI
Novel anti-HIV carrageenan-based on microbicides
$1,543,420Population Council · P01 · FY2004 · HD
Primary Immune Deficiency Treatment Consortium
$1,543,394Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2017 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2018 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2019 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2016 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2020 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,543,286Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,543,278Duke University · U01 · FY2004 · AI
ACISR for Late-Life Depression Prevention
$1,543,178Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · MH
Center for Perioperative Mental Health
$1,543,160Eric J Lenze · Washington University · P50 · FY2022 · MH
Adoptive Cell Transfer Immunotherapy of Cancer
$1,543,070Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Gene therapy of cancer
$1,543,070Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD
$1,543,069Douglas R Galasko · University Of California, San Diego · U01 · FY2007 · AG
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH
$1,543,051Jill G. Joseph · Children'S Research Institute · UL1 · FY2010 · RR
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network
$1,543,038James A Tonascia · Johns Hopkins University · U01 · FY2017 · DK
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,542,920University Of Southern California · U01 · FY2002 · AI
1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)
$1,542,812Claudia R Morris · Emory University · UH3 · FY2021 · HL
Center for Research Translation of Systemic Exon-skipping in Muscular Dystrophy
$1,542,768Eric P Hoffman · Children'S Research Institute · P50 · FY2014 · AR
Gene and Pharmacological Therapies for Cystic Fibrosis
$1,542,765William B. Guggino · Johns Hopkins University · P01 · FY2007 · HL